BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Diagnosis
11 results:

  • 1. Advances in the role of heat shock protein 90 in prostate cancer.
    Fu Z; Jia B
    Andrologia; 2022 May; 54(4):e14376. PubMed ID: 35075667
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcoma.
    Yao ZP; Zhu H; Shen F; Gong D
    Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):380-390. PubMed ID: 34767669
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of hsp90
    Zhou W; Yang Y; Wang Z; Liu Y; Lari Najafi M
    J Healthc Eng; 2021; 2021():6929971. PubMed ID: 34721827
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular Chaperones in Osteosarcoma: diagnosis and Therapeutic Issues.
    Lallier M; Marchandet L; Moukengue B; Charrier C; Baud'huin M; Verrecchia F; Ory B; Lamoureux F
    Cells; 2021 Mar; 10(4):. PubMed ID: 33808130
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation hsp90 inhibitor in Saos-2 osteosarcoma cells.
    Özgür A
    J Chemother; 2021 Dec; 33(8):554-563. PubMed ID: 33794753
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Aggregation-Induced Emission Probe for Specific Turn-On Quantification of Soluble Transferrin Receptor: An Important Disease Marker for Iron Deficiency Anemia and Kidney Diseases.
    Zhang R; Sung SHP; Feng G; Zhang CJ; Kenry ; Tang BZ; Liu B
    Anal Chem; 2018 Jan; 90(2):1154-1160. PubMed ID: 29271190
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases.
    Udagawa H; Niho S; Kirita K; Umemura S; Matsumoto S; Yoh K; Goto K
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1075-1082. PubMed ID: 28220258
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Organ-specific efficacy of hsp90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer.
    Takeuchi S; Fukuda K; Arai S; Nanjo S; Kita K; Yamada T; Hara E; Nishihara H; Uehara H; Yano S
    Int J Cancer; 2016 Mar; 138(5):1281-9. PubMed ID: 26379118
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. hsp90 inhibition results in apoptosis of Philadelphia acute lymphoblastic leukaemia cells: an attractive prospect of new targeted agents.
    Tavernier E; Flandrin-Gresta P; Solly F; Rigollet L; Cornillon J; Augeul-Meunier K; Stephan JL; Montmartin A; Viallet A; Guyotat D; Campos L
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1753-8. PubMed ID: 22706881
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy.
    Trieb K; Gerth R; Holzer G; Grohs JG; Berger P; Kotz R
    Br J Cancer; 2000 Jan; 82(1):85-7. PubMed ID: 10638971
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Gastric cancer and metastasis to the brain.
    York JE; Stringer J; Ajani JA; Wildrick DM; Gokaslan ZL
    Ann Surg Oncol; 1999 Dec; 6(8):771-6. PubMed ID: 10622506
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.